IL-12p40/IL-23p40 Blockade With Ustekinumab Decreases the Synovial Inflammatory Infiltrate Through Modulation of Multiple Signaling Pathways Including MAPK-ERK and WntRenée H. Fiechter, M. G. H. Van de Sande|Frontiers in Immunology|2021Cited by 30